Condition
Cognitive Decline, Mild
Total Trials
5
Recruiting
2
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Recruiting2
Completed2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07596186Active Not RecruitingPrimary
Predict Early Cognitive Changes in a Healthy Elderly Population by Passively Recording Sensor Data From Mobile Devices
NCT06362707Phase 2RecruitingPrimary
Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
NCT06495190Not ApplicableRecruitingPrimary
Cognition, Flavonoids, Exercise, Gut Microbiome
NCT05983913Not ApplicableCompletedPrimary
Effects of Wearable Sensor-based Interactive Cognitive-motor Training in Older Adults.
NCT04939961Not ApplicableCompletedPrimary
Effects of Hericium Erinaceus on Microbiota and Cognition
Showing all 5 trials